Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism model
Florian olde Heuvel(Universität Ulm), Francesco Roselli(University Hospital Ulm), Albert C. Ludolph(German Center for Neurodegenerative Diseases), P. Zahn(University Hospital Münster), Alberto Catanese(Universität Ulm), Elmira Khatamsaz(Universität Ulm), Najwa Ouali Alami(Universität Ulm), Esther Pogatzki‐Zahn(University Hospital Münster), Stefanie Grabrucker(University College Cork), Dhruva Deshpande(Universität Ulm), Sarah Woelfle(Universität Ulm), Michael Schön(Universität Ulm), Jens Michaelis(Universität Ulm), Tobias M. Boeckers(Universität Ulm), Chiara Verpelli(SIB Swiss Institute of Bioinformatics), Sanjay Jain(Washington University in St. Louis), H. Wilhelm(Universität Ulm), Oumayma Aousji(Universität Ulm)
Cited by 37
Related Papers
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
|Nature Neuroscience|2015|782
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis
|Nature Genetics|2009|404
ProSAP/Shank proteins – a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease
|Journal of Neurochemistry|2002|348
TDP-43 is intercellularly transmitted across axon terminals
|The Journal of Cell Biology|2015|324